AI could revolutionize drug discovery. But how can we regulate it?

By Cody Mello-Klein November 19, 2025

From the beginning of the modern AI revolution, health care has been one of the most promising areas for innovation. It is already playing a key role in the discovery and development of new drugs that treat everything from cancer to tropical diseases.

However, while artificial intelligence is advancing at warp speed in the biotech and health industries, the regulations designed to keep this technology in check have lagged behind. Researchers at Northeastern University have developed a tool to address that gap and get everyone on the same page about AI’s lifesaving and potentially problematic impact on health care.

“There are thousands of documents on how to regulate AI and AI products from all kinds of places all over the world, and you would not be surprised to know that they contradict each other,” says Jared Auclair, a Northeastern chemistry and chemical biology professor and dean of the College of Professional Studies. “We’ve used AI to develop a tool to aggregate all those things and then to try to give you best practices and thoughts on what to do with them.”

Read more at Northeastern Global News

Photo by Matthew Modoono/Northeastern University

Sign up for CONNECTS.

The College of Science newsletter delivered straight to your inbox.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.